Point-of-care ultrasound in diabetology improves cardiovascular risk assessment, detects liver steatosis, identifies lipohypertrophy more sensitively than clinical exam, and assesses nutritional status.
Does Point-of-Care Ultrasound improve clinical assessment in diabetology?
Point-of-care ultrasound is a versatile tool in diabetology that enhances the detection of cardiovascular risk, liver steatosis, lipohypertrophy, and muscle wasting.
Ultrasound is increasingly used in daily clinical practice to improve the efficiency of the clinical examination. In this article, we reviewed its various possible uses in the field of diabetology. The ultrasonic evaluation of the carotid arteries (plaques and intima media thickness) allows improving the assessment of the cardiovascular risk. Steatosis can be detected relatively easily on liver ultrasound. Ultrasound also allows a more sensitive detection of lipohypertrophy resulting in glycemic fluctuations and thus increasing the risk of hypoglycemia than the clinical examination. Finally, muscle ultrasound appears to be a promising tool to assess the nutritional status and its consequences (e.g., falls).
X. Vandemergel (Mon,) conducted a review in Diabetes. Point-of-Care Ultrasound (POCUS) vs. Clinical examination was evaluated. Point-of-care ultrasound in diabetology improves cardiovascular risk assessment, detects liver steatosis, identifies lipohypertrophy more sensitively than clinical exam, and assesses nutritional status.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: